Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,239,031
Closed -$11.4M 20
2025
Q2
$11.4M Buy
1,239,031
+917,229
+285% +$9.38M 3.46% 11
2025
Q1
$3.87M Sell
321,802
-420,772
-57% -$5.5M 1.99% 17
2024
Q4
$8.2M Buy
+742,574
New +$10.4M 1.7% 22
2023
Q2
Sell
-160,269
Closed -$1.36M 69
2023
Q1
$1.36M Buy
+160,269
New +$1.45M 0.41% 40
2022
Q3
Sell
-217,767
Closed -$2.53M 51
2022
Q2
$2.53M Buy
+217,767
New +$2.57M 1.03% 27
2021
Q3
Sell
-496,826
Closed -$6.29M 33
2021
Q2
$6.29M Buy
496,826
+415,801
+513% +$4.57M 2.06% 12
2021
Q1
$1.05M Buy
+81,025
New +$747K 0.26% 33

Other funds holding EOLS

Tri Locum Partners's EOLS Position: Q3 2025 in Review

Tri Locum Partners sold out of Evolus (EOLS) in Q3 2025, closing a stake of 1,239,031 shares — an estimated $11.4M sold.

Tri Locum Partners first reported a position in EOLS in Q1 2021 and held it in 7 quarters. The position peaked at $11.4M in Q2 2025. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Tri Locum Partners reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Tri Locum Partners sold 1,239,031 Evolus shares in Q3 2025, an estimated $11.4M.
  • Tri Locum Partners first reported a position in Evolus in Q1 2021 and held it in 7 quarters.
  • Tri Locum Partners's Evolus position peaked at $11.4M in Q2 2025.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Tri Locum Partners's 13F filing for Q3 2025, filed 14 Nov 2025.